Take a deep breath, Friends: the world’s first (seemingly) commercially viable inhalable insulin product is here. Today, Sanofi has officially launched MannKind’s long-awaited Afrezza, and we hear the product is already appearing in some pharmacies nationwide. Housed in a tiny, handy inhaler device, Afrezza is said to bring not only convenience, but also some new medical benefits to the world of rapid-acting insulin.

Read more